[Pulmonary fibrosis after busulfan therapy].
After a short review concerning the side-effect of busulfan (myleran) a case of a myleran lung in a 45-year-old male patient is described who received altogether 408.0 mg myleran, as he suffered from a chronic myeloic leucosis; the special literature is cited and the developmental mechanisms are discussed.
D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000139:chemically induced*
D002066:Busulfan
Lungenfibrose nach Busulfantherapie